KANG Wei
School
School of Pharmaceutical Science and Technology
Professional Title
Associate professor
Administrative Appointments
Associate Professor
Discipline
Real World Evidence
Contact Information
weikang@tju.edu.cn
Education Background
- Doctoral degree| The University of Hong Kong| Pharmacology and Pharmacy| 2025
- Master’s Degree| China Pharmaceutical University| Microbial and Biochemical Pharmacy| 2016
- Bachelor’s Degree| China Pharmaceutical University| Biotechnology| 2013
Research Interests
- Real-world evidence and pharmacoepidemiology: medication safety and effectiveness across oncology, infectious diseases, cardiovascular, and mental health
- Pharmacoeconomics and health technology assessment
Courses
-
No content
Professional Membership
-
No content
Positions & Employments
-
2025.9-Now
School of Pharmaceutical Science and Technology | Tianjin University -
2025.5-2025.9
AI and Pharmaceuticals in Non-Communicable Diseases (NCDs) | Laboratory of Data Discovery for Health (D24H) -
2025.1-2025.4
AI and Pharmaceuticals in Non-Communicable Diseases (NCDs) | Laboratory of Data Discovery for Health (D24H)
Academic Achievements
- Papers
- [1] Kang, W., Huang, C., Yan, V. K. C., Wei Y., Shami, J. J. P., Li, S. T. H., Yang, Y., Ye, X., Tang, J., Lee, S. F., Lee, V. H. F., Chan, S. L., Helali, A. EI., Lam, K., Ngan, R. K. C., Wong, I. C. K., & Chan, E. W. (2024). Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thromboembolism: A population-based cohort study. Nature Communications, 15(1), 5657.
- [2] Kang, W.*, Shami, J. J. P.*, Yan, V. K. C., Ye, X., Blais, J. E., Li, X., Lee, V. H. F., Chui, C. S. L., Lai, F. T. T., Wan, E. Y. F., Wong, C. K. H., Wong, I. C. K., & Chan, E. W. (2022). Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study. Journal of Hematology & Oncology, 15(1), 66.
-
- [3] Kang, W., Peng, K., Yan, V. K. C., Al-Badriyeh, D., Lee, S. F., Yiu, E. H. H., Wei, Y., Li, S. T. H., Ye, X., Helali, A. EI., Lam, K., Lee, V. H. F., Wong, I. C. K., & Chan, E. W. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thromboembolism: A Cost-effectiveness Analysis. Journal of Pharmaceutical Policy and Practice, 17(1), 2375269.
- [4] Wei, Y., Yan, V. K. C., Kang, W., Wong, I. C. K., Castle, D. J., Gao, L., Chui, C. S. L., Man, K. K. C., Hayes, J. F., Chang, W. C., & Chan, E. W. (2022). Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia. JAMA Network Open, 5(7), e2224163.
- [5] Huang, C. *, Wei, Y. *, Yan, V. K. C., Ye, X., Kang, W., et al. (2023). Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. Lancet Psychiatry, 10(6), 403-413.
- [6] Ye, X. *, Ma, T. *, Blais, J. E., Yan, V. K. C., Kang, W., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Tse, H. F., Siu, C. W., Wong, I. C. K., & Chan, E. W. (2022). Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research, 118(10), 2329-2338.
- [7] Ye, X., Huang, C., Yan, V. K. C., Kang, W., Fan, M., et al. (2023). Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. European Heart Journal-Cardiovascular Pharmacotherapy, 9(5), 403-412.
- [8] Ye, X. *, Yan, V. K. C. *, Yiu, H. H. E., Shami, J. J. P., Kang, W., Ma, T., Qin, X., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Wong, I. C. K., & Chan, E. W. (2023). BNT162b2 or CoronaVac Vaccinations Are Associated With a Lower Risk of Myocardial Infarction and Stroke After SARS-CoV-2 Infection Among Patients With Cardiovascular Disease. Journal of the American Heart Association, 12(9), e029291.
- [9] Ye, X. *, Blais, J. E. *, Ng, V. W. S., Castle, D., Hayes, J. F., Wei, Y., Kang, W., Gao, L., Yan, V. K. C., Wong, I. C. K., & Chan, E. W. (2023). Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study. Journal of Affective Disorders, 320, 421-427.
- [10] Kang, W. *, Liu, H. *, Ma, L., Wang, M., Wei, S., Sun, P., Jiang, M., Guo, M., Zhou, C., & Dou, J. (2017). Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids. European Journal of Pharmaceutical Sciences, 105, 169-177.
- [11] Li, B. *, Kang, W. *, Liu, H., Wang, Y., Yu, C., Zhu, X., Dou, J., Cai, H., & Zhou, C. (2016). The antimicrobial activity of Cbf-K16 against MRSA was enhanced by beta-lactamantibiotics through cell wall non-integrity. Archives of Pharmacal Research, 39(7), 978-988.
- [12] Ma, L., Wang, Y., Wang, M., Tian, Y., Kang, W., Liu, H., Wang, H., Dou, J., & Zhou, C. (2016). Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria. Biomaterials, 87, 32-45.